Is this consistent with "legacy effect"? the patients who received DMX in this period received PBO previously, so how would they show some persistence of effect? Or am I missing something here. The press release is unfortunately not perticularly clear. Doesnt the fact that the "second baseline" value for the PBO group in fig 2 is close to zero suggest there is no legacy effect, given that these patients are the ones who were on DMX 6 weeks previously? Let me know if I've miss read this.
i never thought the "legacy effect" stuff sounded perticularly robust.
the study design looks like a way of getting a second bite at the Apple with a single patient cohort, whilst boosting recruitment as all patients know they will receive study drug.
this reads as positive to me and shows a greater treatment effect than the first study period, which is readily attributable to the variability of disease and small patient population.
question would then be, was period 2 fortunate to show a larger treatment effect, or was period 1 unfortunate to show a small one. Perhaps a bit of both?
all in all, encouraging result
- Forums
- ASX - By Stock
- DXB
- Ann: Dimerix Plans for Next Study in Diabetic Kidney Disease
Ann: Dimerix Plans for Next Study in Diabetic Kidney Disease, page-6
-
- There are more pages in this discussion • 164 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
51.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $280.6M |
Open | High | Low | Value | Volume |
51.5¢ | 54.5¢ | 51.0¢ | $1.715M | 3.301M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 365433 | 51.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
51.5¢ | 19658 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 348488 | 0.510 |
7 | 159577 | 0.505 |
9 | 326933 | 0.500 |
6 | 141020 | 0.495 |
8 | 79503 | 0.490 |
Price($) | Vol. | No. |
---|---|---|
0.520 | 4807 | 1 |
0.535 | 6099 | 1 |
0.540 | 230559 | 3 |
0.545 | 8075 | 2 |
0.550 | 19750 | 3 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online